Page last updated: 2024-08-26

3,4-dihydroxyphenylglycol and Cancer of Prostate

3,4-dihydroxyphenylglycol has been researched along with Cancer of Prostate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
deAndrés-Galiana, EJ; Feng, LR; Fernández-Martínez, JL; Saligan, LN; Wolff, BS; Zaal, KJM	1

Other Studies

1 other study(ies) available for 3,4-dihydroxyphenylglycol and Cancer of Prostate

Article	Year
mGluR5 mediates post-radiotherapy fatigue development in cancer patients. Translational psychiatry, 2018, 05-30, Volume: 8, Issue:1 Topics: Aged; Fatigue; Genome-Wide Association Study; Humans; Jurkat Cells; Machine Learning; Male; Methoxyhydroxyphenylglycol; Middle Aged; NF-kappa B; Prostatic Neoplasms; Pyridines; Radiotherapy; Radiotherapy Dosage; Receptor, Metabotropic Glutamate 5; T-Lymphocytes; Transcriptome	2018

Article

Year

mGluR5 mediates post-radiotherapy fatigue development in cancer patients.

Translational psychiatry, 2018, 05-30, Volume: 8, Issue:1

Topics: Aged; Fatigue; Genome-Wide Association Study; Humans; Jurkat Cells; Machine Learning; Male; Methoxyhydroxyphenylglycol; Middle Aged; NF-kappa B; Prostatic Neoplasms; Pyridines; Radiotherapy; Radiotherapy Dosage; Receptor, Metabotropic Glutamate 5; T-Lymphocytes; Transcriptome

2018